Advertisement

Veradigm Inc. MDRX

Set alert

Price alert · MDRX

All alert types
4.74 USD +0.14 +3.04%

At close · Feb 5

4.80 Day range 4.89
3.25 52-week range 6.00
YTD
-1.25%
1 year
+7.73%
Open
4.80
Prev close
4.60
Mkt cap
516.62M
Vol
9.96K
Avg vol
86.48K
EPS
-2.52
P/E
0.00
Div yield
0.00%
More statistics
Low
4.80
High
4.89
Forward P/E
6.52
Beta
0.70
Short ratio
3.92
Inst. own
106.79%
Dividend
0.00
Ex-div date
Oct 6, 2008
Earnings
Jan 4, 2024
50-d avg
9.22
200-d avg
11.81
1y target
15.00

2Y chart

Chart tools
Interval

Signals (166)
NameDateAgo
SMA: BullishOct 30, 20261 day ago
SMA: BullishOct 30, 20261 day ago
SMA: BearishOct 29, 20262 days ago
SMA: BearishOct 29, 20262 days ago
SMA: BullishOct 28, 20263 days ago
SMA: BullishOct 28, 20263 days ago
SMA: BearishOct 26, 20265 days ago
SMA: BearishOct 26, 20265 days ago
SMA: BullishOct 22, 20261 week ago
SMA: BearishOct 20, 20261 week ago
SMA: BearishOct 20, 20261 week ago
MACD: Sell SignalOct 15, 20262 weeks ago
SMA: BullishSep 24, 20261 month ago
SMA: BullishSep 21, 20261 month ago
SMA: BearishSep 18, 20261 month ago
SMA: BearishSep 17, 20261 month ago
MACD: Buy SignalSep 16, 20261 month ago
SMA: BullishSep 14, 20261 month ago
SMA: BearishSep 9, 20261 month ago
SMA: BullishSep 3, 20261 month ago
SMA: BearishSep 2, 20261 month ago
MACD: Sell SignalAug 25, 20262 months ago
SMA: BearishAug 24, 20262 months ago
SMA: BullishAug 17, 20262 months ago
SMA: BearishAug 14, 20262 months ago
SMA: BullishAug 12, 20262 months ago
SMA: BearishAug 11, 20262 months ago
SMA: BullishAug 10, 20262 months ago
MACD: Buy SignalAug 10, 20262 months ago
MACD: Sell SignalAug 3, 20262 months ago
SMA: BearishJul 31, 20263 months ago
SMA: BullishJul 23, 20263 months ago
MACD: Buy SignalJul 23, 20263 months ago
SMA: BearishJul 17, 20263 months ago
SMA: BullishJul 16, 20263 months ago
SMA: BearishJul 15, 20263 months ago
SMA: BullishJul 14, 20263 months ago
SMA: BearishJul 13, 20263 months ago
SMA: BullishJul 10, 20263 months ago
SMA: BullishJul 7, 20263 months ago
SMA: BearishJul 6, 20263 months ago
SMA: BearishJul 6, 20263 months ago
MACD: Sell SignalJul 6, 20263 months ago
MACD: Buy SignalJun 25, 20264 months ago
MACD: Sell SignalJun 15, 20264 months ago
MACD: Buy SignalJun 5, 20264 months ago
SMA: BullishJun 3, 20265 months ago
SMA: BullishJun 3, 20265 months ago
SMA: BearishJun 2, 20265 months ago
SMA: BearishJun 2, 20265 months ago
MACD: Sell SignalJun 2, 20265 months ago
MACD: Buy SignalMay 28, 20265 months ago
MACD: Sell SignalMay 21, 20265 months ago
SMA: BullishMay 14, 20265 months ago
MACD: Buy SignalMay 14, 20265 months ago
MACD: Sell SignalMay 13, 20265 months ago
SMA: BullishMay 11, 20265 months ago
SMA: BearishMay 8, 20265 months ago
SMA: BearishMay 8, 20265 months ago
SMA: BullishApr 28, 20266 months ago
SMA: BullishApr 28, 20266 months ago
MACD: Buy SignalApr 24, 20266 months ago
SMA: BearishApr 6, 20266 months ago
MACD: Sell SignalApr 6, 20266 months ago
SMA: BullishApr 2, 20267 months ago
SMA: BearishApr 1, 20267 months ago
SMA: BullishMar 31, 20267 months ago
SMA: BearishMar 27, 20267 months ago
SMA: BearishMar 19, 20267 months ago
SMA: BullishMar 18, 20267 months ago
SMA: BearishMar 16, 20267 months ago
SMA: BearishMar 16, 20267 months ago
SMA: BullishMar 13, 20267 months ago
SMA: BullishMar 13, 20267 months ago
SMA: BearishMar 10, 20267 months ago
SMA: BullishMar 9, 20267 months ago
MACD: Buy SignalMar 9, 20267 months ago
MACD: Sell SignalMar 6, 20267 months ago
SMA: BearishMar 2, 20268 months ago
SMA: BearishMar 2, 20268 months ago
SMA: BullishFeb 27, 20268 months ago
SMA: BullishFeb 27, 20268 months ago
MACD: Buy SignalFeb 26, 20268 months ago
SMA: BearishFeb 9, 20268 months ago
SMA: BullishFeb 5, 20268 months ago
SMA: BearishFeb 3, 20269 months ago
SMA: BearishFeb 3, 20269 months ago
SMA: BullishFeb 2, 20269 months ago
SMA: BullishJan 30, 20269 months ago
SMA: BearishJan 29, 20269 months ago
SMA: BearishJan 29, 20269 months ago
MACD: Sell SignalJan 29, 20269 months ago
SMA: BullishJan 22, 20269 months ago
SMA: BullishJan 22, 20269 months ago
SMA: BearishJan 21, 20269 months ago
SMA: BearishJan 21, 20269 months ago
SMA: BullishJan 20, 20269 months ago
SMA: BullishJan 20, 20269 months ago
SMA: BearishJan 16, 20269 months ago
SMA: BearishJan 16, 20269 months ago
SMA: BullishJan 15, 20269 months ago
SMA: BearishJan 9, 20269 months ago
SMA: BullishJan 6, 20269 months ago
MACD: Buy SignalJan 6, 20269 months ago
SMA: BearishJan 2, 202610 months ago
SMA: BearishJan 2, 202610 months ago
SMA: BullishDec 31, 202510 months ago
SMA: BullishDec 31, 202510 months ago
SMA: BearishDec 22, 202510 months ago
SMA: BearishDec 22, 202510 months ago
MACD: Sell SignalDec 19, 202510 months ago
MACD: Buy SignalDec 8, 202510 months ago
SMA: BullishDec 3, 202511 months ago
MACD: Sell SignalDec 3, 202511 months ago
SMA: BearishDec 2, 202511 months ago
MACD: Buy SignalNov 25, 202511 months ago
SMA: BullishNov 21, 202511 months ago
SMA: BullishNov 21, 202511 months ago
SMA: BearishNov 18, 202511 months ago
SMA: BearishNov 18, 202511 months ago
MACD: Sell SignalNov 17, 202511 months ago
SMA: BullishOct 29, 20251 year ago
MACD: Buy SignalOct 29, 20251 year ago
MACD: Sell SignalOct 28, 20251 year ago
MACD: Buy SignalOct 17, 20251 year ago
MACD: Sell SignalOct 16, 20251 year ago
SMA: BullishOct 10, 20251 year ago
SMA: BearishOct 9, 20251 year ago
SMA: BullishOct 7, 20251 year ago
SMA: BearishOct 1, 20251 year ago
SMA: BullishSep 30, 20251 year ago
MACD: Buy SignalSep 30, 20251 year ago
RSI: OversoldSep 25, 20251 year ago
SMA: BearishSep 10, 20251 year ago
MACD: Sell SignalSep 8, 20251 year ago
RSI: OverboughtSep 2, 20251 year ago
MACD: Buy SignalAug 20, 20251 year ago
SMA: BearishAug 14, 20251 year ago
MACD: Sell SignalAug 5, 20251 year ago
MACD: Buy SignalAug 4, 20251 year ago
MACD: Sell SignalJul 21, 20251 year ago
MACD: Buy SignalJul 11, 20251 year ago
MACD: Sell SignalJul 10, 20251 year ago
SMA: BullishJul 9, 20251 year ago
MACD: Buy SignalJul 9, 20251 year ago
SMA: BearishJul 8, 20251 year ago
MACD: Sell SignalJul 8, 20251 year ago
RSI: OverboughtJul 2, 20251 year ago
MACD: Buy SignalJun 4, 20251 year ago
SMA: BullishMay 30, 20251 year ago
MACD: Sell SignalMay 29, 20251 year ago
SMA: BearishMay 27, 20251 year ago
SMA: BullishMay 19, 20251 year ago
SMA: BearishMay 16, 20251 year ago
SMA: BullishMay 15, 20251 year ago
RSI: OversoldApr 7, 20251 year ago
MACD: Buy SignalMar 31, 20251 year ago
MACD: Sell SignalMar 24, 20251 year ago
RSI: OversoldMar 24, 20251 year ago
RSI: OversoldMar 20, 20251 year ago
RSI: OversoldFeb 21, 20251 year ago
MACD: Buy SignalFeb 18, 20251 year ago
RSI: OversoldJan 31, 20251 year ago
RSI: OversoldJan 23, 20251 year ago
MACD: Sell SignalJan 16, 20251 year ago
MACD: Buy SignalJan 7, 20251 year ago

Key statistics

Market cap
669.76M
Enterprise value
380.68M
Trailing P/E
7.13
Forward P/E
6.52
PEG ratio
-0.62
Price / sales
0.44
Price / book
0.57
EPS (TTM)
0.86
Beta
0.70
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
3.97%
Revenue (TTM)
1.53B
Revenue growth
5.00%
Free cash flow
155.57M
Total cash
492.60M
Total debt
218.81M
Return on equity
8.93%
Shares outstanding
109.26M
Short % of float
0.00%
50-day average
9.22
200-day average
11.81

Analyst view

Consensus: buy

Buy
Price target (mean) 15.00 +216.5% upside
Target (low)
10.00
Target (mean)
15.00
Target (high)
26.00
Ratings (0m) 20 12 buy · 7 hold · 1 sell
  • Strong buy6
  • Buy6
  • Hold7
  • Sell1
  • Strong sell0

Next earnings

Jan 4, 2024

Expected Jan 4, 2024. Consensus EPS estimate 0.27.

Earnings history

Financials — quick view

All financials
MDRX Revenue — quarterly 151.92M
2018-Q4 20182019-Q1 20192019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 2022
MDRX Net income — quarterly 14.53M
2018-Q4 20182019-Q1 20192019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 2022
MDRX EPS — quarterly 0.13
2018-Q4 20182019-Q1 20192019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 2022

Earnings

MDRX recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Jan 4, 2024Sep 1, 20230.22———
Oct 5, 2023Jun 1, 20230.20———
Jul 6, 2023Mar 1, 20230.14———
Nov 3, 2022Sep 1, 20220.190.23+0.04+21.05%
Aug 4, 2022Jun 1, 20220.160.18+0.02+12.50%
May 5, 2022Mar 1, 20220.200.13-0.07-35.00%

Upgrades / downgrades

MDRX analyst upgrades and downgrades
DateFirmActionFromTo
Oct 9, 2023Stephens & Co.reitEqual-WeightEqual-Weight
Jul 5, 2023Argus ResearchdownBuyHold
Apr 11, 2023Stephens & Co.init—Equal-Weight
Jan 31, 2023Piper SandlerdownOverweightNeutral
Dec 6, 2022Argus ResearchupHoldBuy
Nov 17, 2022JP Morganmain—Underweight

About Veradigm Inc.

Veradigm Inc., a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates through two segments, Hospitals and Large Physician Practices, and Veradigm. The Hospitals and Large Physician Practices segment provides integrated clinical and financial management solutions, which primarily include EHR-related software; and related installation, support and maintenance, outsourcing, private cloud hosting, and revenue cycle management services. The Veradigm segment offers payer and life sciences solutions, which are primarily targeted at payers, life sciences companies, and other healthcare stakeholders; and software applications for patient engagement and EHR software to single-specialty, and small and mid-sized physician practices, including related clinical, financial, administrative, and operational solutions. Its solutions enable clients to transition, analyze, and coordinate care, and enhance the healthcare delivery across the care community. The company serves physicians, hospitals, governments and militaries, health systems, health plans, life-sciences companies, retail clinics, surgery centers, retail pharmacies, pharmacy benefit managers, insurance companies, employer wellness clinics, consumers, lab companies, urgent care facilities, and venture capital firms, as well as post-acute organizations, such as home health and hospice agencies. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

Country
United States
Website
veradigm.com

News

Your note

Sign in to keep a note on MDRX — it syncs with the Stock Master app.

Insider holders

MDRX insider holders
InsiderRelationLatest transactionDateShares held
ALTMAN ELIZABETH ANNDirectorStock Award(Grant)Jun 26, 202235,552
GARRISON P GREGORYDirectorStock Award(Grant)Jun 26, 202260,569
HAMMOND LISAOfficerStock Award(Grant)Feb 25, 202470,416
JAMES THOMAS LANGANPresidentStock Award(Grant)Feb 25, 2024180,659
JONES LEAHChief Financial OfficerSaleSep 12, 202298,362
JUDGE JONATHAN JAMESDirectorStock Award(Grant)Jun 26, 2022132,487

Institution ownership

MDRX institution ownership
Holder% heldSharesValueReported
Blackrock Inc.18.05%19,720,678248.48MJun 29, 2023
Vanguard Group Inc13.00%14,204,004178.97MJun 29, 2023
Dimensional Fund Advisors LP8.27%9,035,018113.84MJun 29, 2023
State Street Corporation3.69%4,034,00550.83MJun 29, 2023
Shaw D.E. & Co., Inc.3.49%3,816,65548.09MJun 29, 2023
William Blair Investment Management, LLC3.43%3,751,56747.27MJun 29, 2023

Fund ownership

MDRX fund ownership
Holder% heldSharesValueReported
iShares Core S&P Smallcap ETF6.75%7,376,95796.93MSep 29, 2023
Vanguard Total Stock Market Index Fund2.97%3,246,83940.91MJun 29, 2023
Vanguard Small-Cap Index Fund2.45%2,679,65933.76MJun 29, 2023
DFA U.S. Small Cap Value Series2.28%2,491,48433.68MJul 30, 2023
iShares Russell 2000 ETF2.28%2,494,90333.38MAug 30, 2023
Undiscovered Managers Behavioral Value Fund1.93%2,112,95426.62MJun 29, 2023
Advertisement